Skip to main content
Premium Trial:

Request an Annual Quote

Baylor to Use Illumina's Infinium Products in Developmental Diseases Studies

NEW YORK (GenomeWeb News) – The Baylor College of Medicine's Medical Genetics Laboratories will use Illumina's Infinium High-Density DNA Analysis products in genomic studies of developmental disorders.

Specifically, the Houston-based lab intends to use Illumina's arrays for studying genomic imprinting and its role in developmental diseases such as Prader-Willi syndrome, Angelman syndrome, and other disorders caused by uniparental disomy.

"Results from early tests show that we can quickly generate high-quality data using Illumina's SNP arrays, providing us with the information required to more rapidly and accurately identify causative aberrations in the genome," said Arthur Beaudet, chair of the department of molecular and human genetics at Baylor college of Medicine, in a statement.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.